However, pelvic floor pain is not tied to bladder conditions among women with interstitial cystitis or bladder pain syndrome<\/p>\n<\/h3>\n
By Lori Solomon HealthDay Reporter<\/b><\/p>\n
<\/b><\/p>\n
TUESDAY, March 7, 2023 (HealthDay News) — Pelvic floor myofascial pain (PFMP) is not associated with bladder conditions among women with interstitial cystitis or bladder pain syndrome (IC\/BPS), according to a study recently published in Pain Physician<\/em>.<\/p>\n Wan-Ru Yu, from Buddhist Tzu Chi Medical Foundation in Hualien, Taiwan, and colleagues explored the relationship between PFMP and treatment outcomes in 65 women (mean age, 57 years) with IC\/BPS. Vaginal digital examination was performed at baseline; the visual analog scale was used to quantify PFMP severity.<\/p>\n The researchers found that patients with more severe PFMP had a significantly higher rate of dyspareunia, more comorbidities, a higher number of PFMP sites, and a higher O’Leary-Sant symptom score. There was no significant correlation between PFMP severity and bladder conditions, measured subjectively or objectively. There was a significant negative association observed between PFMP severity as measured on a visual analog scale and the Global Response Assessment score.<\/p>\n “PFMP might affect the subjective results of IC\/BPS treatment but not the bladder condition,” the authors write. “Therefore, in the future treatment of patients with IC\/BPS, digital vaginal examinations of pelvic floor muscles should be performed and focused more on the PFM-related conditions, and necessary PFM treatments, such as the vaginal pelvic floor muscle massage, should be scheduled.”<\/p>\n Abstract\/Full Text (subscription or payment may be required)<\/a><\/p>\n <\/i><\/p>\n